全文获取类型
收费全文 | 2371608篇 |
免费 | 198028篇 |
国内免费 | 4204篇 |
专业分类
耳鼻咽喉 | 34264篇 |
儿科学 | 72746篇 |
妇产科学 | 62928篇 |
基础医学 | 334864篇 |
口腔科学 | 67519篇 |
临床医学 | 215509篇 |
内科学 | 468567篇 |
皮肤病学 | 47929篇 |
神经病学 | 200782篇 |
特种医学 | 95956篇 |
外国民族医学 | 886篇 |
外科学 | 360379篇 |
综合类 | 56216篇 |
现状与发展 | 1篇 |
一般理论 | 977篇 |
预防医学 | 190598篇 |
眼科学 | 55462篇 |
药学 | 177518篇 |
4篇 | |
中国医学 | 4365篇 |
肿瘤学 | 126370篇 |
出版年
2018年 | 24203篇 |
2016年 | 20575篇 |
2015年 | 23278篇 |
2014年 | 33533篇 |
2013年 | 50827篇 |
2012年 | 68732篇 |
2011年 | 72272篇 |
2010年 | 42469篇 |
2009年 | 40860篇 |
2008年 | 68755篇 |
2007年 | 73095篇 |
2006年 | 74000篇 |
2005年 | 72033篇 |
2004年 | 69331篇 |
2003年 | 67012篇 |
2002年 | 66260篇 |
2001年 | 112449篇 |
2000年 | 116525篇 |
1999年 | 98334篇 |
1998年 | 27858篇 |
1997年 | 25522篇 |
1996年 | 25447篇 |
1995年 | 24609篇 |
1994年 | 23159篇 |
1993年 | 21552篇 |
1992年 | 79386篇 |
1991年 | 76393篇 |
1990年 | 73575篇 |
1989年 | 70841篇 |
1988年 | 65846篇 |
1987年 | 64800篇 |
1986年 | 61334篇 |
1985年 | 58399篇 |
1984年 | 44222篇 |
1983年 | 37657篇 |
1982年 | 22886篇 |
1981年 | 20332篇 |
1980年 | 19034篇 |
1979年 | 41299篇 |
1978年 | 28985篇 |
1977年 | 24346篇 |
1976年 | 22832篇 |
1975年 | 23964篇 |
1974年 | 29638篇 |
1973年 | 28042篇 |
1972年 | 26226篇 |
1971年 | 24151篇 |
1970年 | 22752篇 |
1969年 | 21087篇 |
1968年 | 19135篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
R. E. J. Ryder 《Diabetic medicine》2015,32(3):305-313
On 8 April 2014, a US jury ordered Takeda and Eli Lilly to pay $9 bn in punitive damages after finding that they had concealed the cancer risks associated with pioglitazone. By contrast, on 28 August 2014, the long‐awaited outcome of the 10‐year Kaiser Permanente Northern California study was announced. That study was specifically designed to investigate whether patients exposed to pioglitazone were at an increased risk of bladder cancer and found no association; thus, at last, the controversial issue has been resolved. A review, in retrospect, of the story of the proposed link between pioglitazone and bladder cancer reveals flaws at every stage. In 2012, a BMJ editorial, in keeping with some other contemporary reports, stated ‘it can confidently be assumed that pioglitazone increases the risk of bladder cancer’. Examination of the information which led to such a statement shows that: 1) the pre‐clinical findings of bladder cancer in male rats is not indicative of human risk; 2) there is no association between bladder cancer and pioglitazone in randomized controlled trials, once cases that could not plausibly be related to treatment are removed; and 3) the observational studies that have suggested a link have over‐extrapolated from the data: pioglitazone‐treated patients had more risk factors for bladder cancer than those not treated with pioglitazone. Meanwhile careful study of randomized controlled trials shows evidence of cardiovascular benefit from pioglitazone in Type 2 diabetes, a condition which results, more than anything, in premature cardiovascular death and morbidity. 相似文献
152.
153.
154.
155.
156.
157.
Naveen B.S. M.T. Mohan J. Tharayil S.T. Joseph 《International journal of oral and maxillofacial surgery》2021,50(8):1003-1008
A local pedicled vascularized bone flap can prevent the morbidity and cost of free bone flap surgery in small segmental bone defects or long cartilaginous defects of the head and neck. Such flaps can also be useful in patients who are high risk for surgery. The periosteal vascularity of the mandible can be used to design islanded facial artery-based bone flaps, which can be utilized to that extent. Two patients with a small segmental mandibulectomy defect and one patient with a long cricotracheal resection defect underwent reconstruction using three different designs of islanded facial artery osteomyomucosal/osseous flap (iFOMM). The patients had a minimum follow-up period of 18 months. All flaps were successful, with satisfactory healing and without any functional deficit or disease at last follow-up. 相似文献
158.
159.
160.